H. Raftopoulos

Clinical Predictors of Metastatic Disease to the Brain from Non–Small Cell Lung Carcinoma: Primary Tumor Size, Cell Type, and Lymph Node Metastases

Amol Mujoomdar, John H. M. Austin, Rohin Malhotra et al. · Radiology · 2007 · 232 citations

Tumor Innervation, Oncologic Imaging, Brain Metastases +19

Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies

H. Raftopoulos, Abderrahmane Laadem, Paul J. Hesketh et al. · Supportive Care in Cancer · 2015 · 65 citations · Full text

Histologic Assessment of Non–Small Cell Lung Carcinoma after Neoadjuvant Therapy

Xiaolin Liu‐Jarin, Mark Stoopler, H. Raftopoulos et al. · Modern Pathology · 2003 · 53 citations

Medicine, Surgical Pathology, Pathology +10

A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer

Ramesh K. Ramanathan, Joel Picus, H. Raftopoulos et al. · Cancer Chemotherapy and Pharmacology · 2007 · 35 citations

Medicine, Novel Taxane Analogue, Pharmacology +8

Phase IB study of eribulin mesylate in combination with carboplatin in patients with advanced solid tumors.

Umang Swami, Daniel P. Petrylak, H. Raftopoulos et al. · Journal of Clinical Oncology · 2010 · 20 citations

Pathology, Pharmacotherapy, Metronomic Chemotherapy +16